Target validation

CEIDR has access and handling facilities for all major human and animal pathogens, including vector-borne pathogens such as malaria, dengue and Zika. Through a range of leading technology platforms, including those housed within the Medical Research Council Centre for Genomic Research, the Centre for Preclinical Imaging, and Centre for Proteomics, we can facilitate validation and manipulation of biological targets and validation of biomarkers to support preclinical and clinical product development programmes.